Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04195932 · ClinicalTrials.gov registry record · NA
Exercise as a Modulator of Immune Risk Factors for Ischemic Heart Disease
A NA study of Heart Diseases, sponsored by East Tennessee State University.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT04195932 is a NA study of Heart Diseases that has completed, run by East Tennessee State University. The registered enrollment target is 52 participants, below the 5,532-participant average among 85 other Heart Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04195932, a NA study of Heart Diseases, has completed, sponsored by East Tennessee State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
A before and after study involving 43 adult subjects at risk of having ischemic heart disease. Subjects underwent 6 months of supervised moderate intensity aerobic and resistive exercise training. Blood samples were obtained at entry and at 6 months for measurement of complement (C3), CRP, blood lipid levels, lymphocyte phenotypes, and for the isolation, culture, and measurement of the spontaneous and phytohemagglutinin-induced secretion of proatherogenic and antiatherogenic cytokines by their peripheral blood mononuclear cells (PBMC).
Conditions Studied
Interventions
- OTHER Exercise training
Study Locations (1)
Tennessee
- James H. Quillen College of Medicine - Johnson City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 1996-12 |
| Est. Completion | 1998-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04195932
The ClinicalTrials.gov registry entry for NCT04195932 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,532-participant average among 85 other Heart Diseases trials with a reported enrollment target (99% lower). The listed sponsor is East Tennessee State University, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Diseases appearing as the primary indexed condition, and to 1 intervention - of which Exercise training is the first listed.
NCT04195932 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT04195932 about?
NCT04195932 is a clinical study titled "Exercise as a Modulator of Immune Risk Factors for Ischemic Heart Disease". A before and after study involving 43 adult subjects at risk of having ischemic heart disease. Subjects underwent 6 months of supervised moderate intensity aerobic and resistive exercise training. Blood samples were obtained at entry and at 6 months for measurement of complement (C3), CRP, blood lip...
What is the current status of trial NCT04195932?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 1996-12. Estimated completion is 1998-05.
What conditions does trial NCT04195932 study?
This clinical trial studies the following conditions: Heart Diseases.
What interventions are being tested in trial NCT04195932?
The interventions under investigation include: Exercise training (OTHER).
Who is sponsoring clinical trial NCT04195932?
This trial is sponsored by East Tennessee State University, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04195932 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Angiography and Electrogram Guided Bachmann Bundle Pacing
RECRUITING · NA
-
Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health
RECRUITING · NA
-
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
RECRUITING · NA
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
RECRUITING · NA
-
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
RECRUITING · NA
-
Use of Bedside Imaging and Community Health Workers for Early Screening and Referral of Pre-symptomatic Stage B Heart Failure in the Emergency Department
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.